All In MedTech

Device Trial Radar · NCT05224011

Non-invasive Continuous Blood Pressure Monitoring

A Prospective Study to Evaluate the Safety and Effectiveness of the Boppli™ in Measuring Mean Arterial Pressure (MAP), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP) as Compared to an Invasive Arterial Reference

Last checked: Nov 20, 2026Latest source record: Mar 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

8

Actual

Start

Jun 22, 2022

Primary completion

Sep 22, 2022

Study completion Sep 22, 2022

Sponsor

Lead sponsor
PyrAmes Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
University of Calgary
First posted
Feb 4, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, up to 12 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The Boppli device was designed to provide continuous non-invasive blood pressure (cNIBP) monitoring for infants, including neonates, in intensive care settings by detecting systolic, diastolic, and mean arterial blood pressure values comparable to that of an invasive arterial line (IAL) within published accuracy criteria. The device consists of an array of capacitive sensors contained in a soft, flexible, biocompatible band. It applies proprietary algorithms to capacitance detections to generate accurate systolic, diastolic, and mean arterial blood pressure and waveform data, then communicates the data to an external device via Bluetooth Low Energy for storage and display. It may be applied to the patient's arm or foot on either side of the body, which is advantageous for infants whose bodies provide limited surface area for medical devices or equipment. It does not require high skin pressure when correctly placed. The device is intended for single use of up to 72 hours and is discarded following use.

Conditions

  • Blood Pressure

Interventions

  • Boppli Infant Blood Pressure MonitorDevice

    The intervention is a medical device for the non-invasive measurement of blood pressure in infants

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assess the accuracy and precision of the Boppli System in continuous blood pressure monitoringTime frame: 6 - 72 Hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Foothills Medical Center Neonatal Intensive Care Unit, NICU 51

    Calgary, Alberta, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.